Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

XXX - Bifidobacterium bifidum + Bifidobacterium longum + Bifidobacterium longum infantis + Lacticaseibacillus casei + Lactobacillus acidophilus + Lactococcus lactis & Type 2 diabetes (T2D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Background

There is growing evidence suggesting a potential link between gut microbiota and various physiological processes associated with type 2 diabetes. Despite this, the impact of multi-strain probiotics on individuals with type 2 diabetes is still not well understood (1).

Study overview

This is a randomized, double-blind, parallel-group, controlled clinical trial studying Bifidobacterium bifidum + Bifidobacterium longum + Bifidobacterium longum infantis + Lacticaseibacillus casei + Lactobacillus acidophilus + Lactococcus lactis or placebo in 136 enrolled patients with Type 2 diabetes (T2D) for 12 weeks (1)
##…

References (Sources)

Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial
Firouzi et al. 2017 Eur J Nutr 56(4): 1535-1550

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!